Home » Andromeda Phase III Trial Costs Weigh on Clal Biotech Results
Andromeda Phase III Trial Costs Weigh on Clal Biotech Results
IDB Holding subsidiary Clal Biotechnology Industries published its financial report for the second quarter of 2007.
Globes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May